文献速递心境障碍

难治性抑郁的遗传相关因素

Genetic Correlates of Treatment-Resistant Depression.
PubMed 文献 · JAMA Psychiatry · 2025-02-26

基于All of Us研究项目中292663名参与者的队列数据,分析61个特征的多基因评分与难治性抑郁的关联。失眠和特定神经质特质的遗传易感性与难治性抑郁风险升高相关,而教育程度和智力评分较高则具保护作用,这些关联在不同定义和独立数据集中一致。在28964名随访个体中,3854名在平均944天内发展为难治性抑郁。

要点

  • 失眠和特定神经质特质的遗传易感性与难治性抑郁风险升高相关。
  • 较高的教育程度和智力评分与难治性抑郁风险降低相关。
  • 上述遗传关联在不同难治性抑郁定义及两个独立数据集中保持一致。

核心结论

  • 队列研究结果表明,与神经质、认知功能和睡眠模式相关的遗传易感性与难治性抑郁的发生显著相关。
  • 这些发现强调了在管理和治疗难治性抑郁时考虑心理社会因素的重要性。
  • 未来研究应侧重于将遗传数据与临床结局相结合,以加深对导致治疗抵抗通路的理解。

研究设计与样本

  • 本研究为队列设计,使用All of Us研究项目中同时具有电子健康记录和基因组数据的参与者。
  • 数据分析于2024年3月27日至2024年10月24日进行。
  • 暴露为来自7个领域的61个独特特征的多基因评分。
  • 主要结局与测量:采用逻辑回归检验多基因评分是否与难治性抑郁(相较于治疗反应性重性抑郁障碍)相关;采用Cox比例风险模型确定从重性抑郁障碍进展为难治性抑郁是否与多基因评分相关。
  • 共纳入292663名参与者(中位[IQR]年龄57(41-69)岁;175981名女性[60.1%])。

主要发现

  • 在发现集(124945名参与者)中,所选多基因评分中有11个与难治性抑郁的关联强于与治疗反应性重性抑郁障碍的关联,涵盖教育、认知、人格、睡眠和气质领域。
  • 失眠的遗传易感性(OR,1.11;95%CI,1.07-1.15)和特定神经质特质(OR,1.11;95%CI,1.07-1.16)与难治性抑郁风险升高相关。
  • 较高的教育程度(OR,0.88;95%CI,0.85-0.91)和智力评分(OR,0.91;95%CI,0.88-0.94)具有保护作用。
  • 这些关联在不同难治性抑郁定义下保持一致(荟萃分析R²>83%),并在All of Us内另外两个独立数据集(全基因组测序多样性数据集104388名和微阵列数据集63330名)中一致。
  • 在28964名随时间随访的个体中,3854名在平均944天(95%CI,883-992天)内发展为难治性抑郁;所有11个先前识别并复制的多基因评分均调节从重性抑郁障碍到难治性抑郁的转化率。

关键数值与推荐

  • 发现集124945名参与者中,11个多基因评分与难治性抑郁的关联强于与治疗反应性重性抑郁障碍的关联。
  • 失眠多基因评分与难治性抑郁风险相关(OR,1.11;95%CI,1.07-1.15)。
  • 特定神经质特质多基因评分与难治性抑郁风险相关(OR,1.11;95%CI,1.07-1.16)。
  • 教育程度多基因评分与难治性抑郁风险相关(OR,0.88;95%CI,0.85-0.91)。
  • 智力多基因评分与难治性抑郁风险相关(OR,0.91;95%CI,0.88-0.94)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Treatment-resistant depression (TRD) is a major challenge in mental health, affecting a significant number of patients and leading to considerable burdens. The etiological factors contributing to TRD are complex and not fully understood. OBJECTIVE: To investigate the genetic factors associated with TRD using polygenic scores (PGS) across various traits and explore their potential role in the etiology of TRD using large-scale genomic data from the All of Us (AoU) Research Program. DESIGN, SETTING, AND PARTICIPANTS: This study was a cohort design with observational data from participants in the AoU Research Program who have both electronic health records and genomic data. Data analysis was performed from March 27 to October 24, 2024. EXPOSURES: PGS for 61 unique traits from 7 domains. MAIN OUTCOMES AND MEASURES: Logistic regressions to test if PGS was associated with treatment-resistant depression (TRD) compared with treatment-responsive major depressive disorder (trMDD). Cox proportional hazard model was used to determine if the progressions from MDD to TRD were associated with PGS. RESULTS: A total of 292 663 participants (median [IQR] age, 57 (41-69) years; 175 981 female [60.1%]) from the AoU Research Program were included in this analysis. In the discovery set (124 945 participants), 11 of the selected PGS were found to have stronger associations with TRD than with trMDD, encompassing PGS from domains in education, cognition, personality, sleep, and temperament. Genetic predisposition for insomnia (odds ratio [OR], 1.11; 95% CI, 1.07-1.15) and specific neuroticism (OR, 1.11; 95% CI, 1.07-1.16) traits were associated with increased TRD risk, whereas higher education (OR, 0.88; 95% CI, 0.85-0.91) and intelligence (OR, 0.91; 95% CI, 0.88-0.94) scores were protective. The associations held across different TRD definitions (meta-analytic R2 >83%) and were consistent across 2 other independent sets within AoU (the whole-genome sequencing Diversity dataset, 104 388, and Microarray dataset, 63 330). Among 28 964 individuals followed up over time, 3854 developed TRD within a mean of 944 days (95% CI, 883-992 days). All 11 previously identified and replicated PGS were found to be modulating the conversion rate from MDD to TRD. CONCLUSIONS AND RELEVANCE: Results of this cohort study suggest that genetic predisposition related to neuroticism, cognitive function, and sleep patterns had a significant association with the development of TRD. These findings underscore the importance of considering psychosocial factors in managing and treating TRD. Future research should focus on integrating genetic data with clinical outcomes to enhance understanding of pathways leading to treatment resistance.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Xu B, Forthman KL, Kuplicki R, et al. Genetic Correlates of Treatment-Resistant Depression. JAMA Psychiatry. 2025. PMID: 40009368. doi:10.1001/jamapsychiatry.2024.4825

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。